2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1- methyl-5-phenyl-,mixt. with 5,5-diphenyl-2,4-imidazolidinedione monosodium salt (8028-72-6)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (1-methylbutyl)-,monosodium salt,mixt. with 5,5-diphenyl-2,4-imidazolidinedione
- 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt, mixt. with t-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and sodium benzoate
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1- methyl-5-phenyl-,mixt. with 5,5-diphenyl-2,4-imidazolidinedione
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, monosodi um salt, mixt. with 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-p yrimidinetrione monosodium salt
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-phenyl-, mixt. with (+-)-alpha-methylbenzeneethanamine sulfate (2:1)
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[3-[4-(dimethylamino)phenyl]-1-methyl-2-propenylidene]-1,3-diphenyl-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-3-methyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-5-ethyl-, mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one
- Ergotaman-3',6',18-trione,12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'a)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt),mixt. with belladonna alkaloids and5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione (9CI)
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(diethoxymethylsilyl)methyl]-,monosodium salt
- Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- phenyl-,compounds,monosodium salt,mixt. with calcium bromide (CaBr2),potassium bromide (KBr) and sodium bromide (NaBr)
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[2-(4-morpholinyl)ethyl]-5-phenyl-, hydrochloride (1:1)
- Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one,N-(4-ethoxyphenyl)acetamide and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-phenyl-, magnesium salt (2:1)
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- (3-methylbutyl)-,mixt. with 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,- 3H,5H)-pyrimidinetrione
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5- phenyl-,compounds,mixt. with 1-[(3,4-dimethoxyphenyl)methyl]-6,7- dimethoxyisoquinoline hydrochloride and 4-(dimethylamino)-1,2-dihydro-1,5- dimethyl-2-phenyl-3H-pyrazol-3-one
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(1-cyclohexen- 1-yl)-5-ethyl-,calcium salt (2:1),mixt. with 7-chloro-1,3-dihydro-1-methyl-5- phenyl-2H-1,4-benzodiazepin-2-one
- Piperidinium,1-ethyl-3-[(hydroxydiphenylacetyl) oxy]-1-methyl-,bromide,mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)- pyrimidinetrione